Skip to main content
. 2003 May;52(5):629–636. doi: 10.1136/gut.52.5.629

Figure 1.

Figure 1

Comparison of antineuronal immunoreactivity evaluated using the blinded grading system. The intensity of immunoreactivity was significantly greater with serum from individuals with achalasia and gastro-oesophageal reflux disease (GORD) than with control serum. Only serum from achalasia and GORD patients demonstrated intense (grade 2) staining.